ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Daunorubicin hydrochloride
C27H30ClNO10
564 g/mol
APIDanger

DAUNORUBICIN HYDROCHLORIDE

CAS23541-50-6EC245-723-4
Category
API
Compound Class
Natural Product
Primary Use
Pharmaceutical Raw Material

Daunorubicin hydrochloride is a chemotherapy medication used in cancer treatment. It is specifically indicated for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma.

pharmaceutical raw material for manufacturing of anticancer formulationsactive pharmaceutical ingredient for injectable preparationslaboratory reference standard for analytical testing

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 23541-50-6

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

StrongSame Parent

Daunorubicin

CAS20830-81-3

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.85

Doxorubicin hydrochloride

CAS25316-40-9

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.85

Epirubicin hydrochloride

CAS56390-09-1

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.85

Doxorubicin

CAS23214-92-8

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.83

Idarubicin hydrochloride

CAS57852-57-0

pharmaceutical raw material

ReferenceSame Category

Deiodoamiodarone

CAS23551-25-9

pharmaceutical raw material

ReferenceSame Category

Clotrimazole

CAS23593-75-1

pharmaceutical raw material

ReferenceSame Category

Quinapyramine dichloride

CAS23609-65-6

pharmaceutical raw material

Safety Reference

Toxic
Toxic
Harmful
Harmful
Health Hazard
Health Hazard
Danger
H301Toxic if swallowed
H302Harmful if swallowed
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
H341Suspected of causing genetic defects
H351Suspected of causing cancer
H360May damage fertility or the unborn child
Identifiers
IUPAC Name

(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride

InChIKey

GUGHGUXZJWAIAS-QQYBVWGSSA-N

SMILES

C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.Cl

Synonyms (52)
  • Daunorubicin hydrochloride (JP18/USP)
  • Daunorubicin hydrochloride, European Pharmacopoeia (EP)
  • Daunorubicin hydrochloride, United States Pharmacopeia (USP)
  • Daunorubicin hydrochloride, meets USP testing specifications
  • Cerubidine
  • Cerubidine (TN)
  • Cloridrato de Daunorubicina
  • DAUNORUBICIN HCL
  • DAUNORUBICIN HYDROCHLORIDE
  • DaunoXome
  • Daunoblastin
  • Daunoblastina
  • Daunoblastine
  • Daunomycin HCL
  • Daunomycin chlorohydrate
  • Daunomycin hydrochloride
  • Daunorubicini Hydrochloridum
  • FI 6339 HYDROCHLORIDE
  • FI 6339 [as the base]
  • Hydrochloride, Daunorubicin
  • NDC 0082-4155
  • Ondena
  • RP 13057 [as the base]
  • RP 13057 hydrochloride
  • Rubidomycin hydrochloride
  • Rubilem
  • Rubomycin